Professor | Duan Ma | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Duan Ma
Contact Information	duanma@fudan.edu.cn
Language ability	English, Chinese
Province	Shanghai

Upload Avatar (500 x 500)

Name

Duan Ma

Contact Information

duanma@fudan.edu.cn

Language ability

English, Chinese

Province

Shanghai

University/Lab Affiliation and Title	Fudan University
Faculty	Basic Medical Sciences
Academic Background & Achievements	2000-2002: Postdoctoral Research, University of New Mexico School of Medicine, Department of Pathology 1998-2000: Postdoctoral Research, Peking Union Medical College/Beijing Union Medical College Hospital, Department of Cardiology 1995-1998: Ph.D. in Biochemistry and Molecular Biology, Shanghai Medical College 1985-1988: Master's in Hematology, Shandong Medical University 1979-1982: Medical Degree, Wuhan University of Science and Technology School of Medicine
Work Experience	2008.5-present: Deputy Director, Birth Defect Research Center, Fudan University 2002.4-present: Deputy Director, Key Laboratory of Metabolic Molecular Medicine, Ministry of Education, Fudan University, Professor 1988.9-2000.9: Director, Thrombosis Research Center, Shandong Third People's Hospital, Associate Chief Physician 1982.8-1985.8: Resident Physician, Internal Medicine, Anyang Steel Company Hospital, Henan
Awards	2015: First Prize, China Maternal and Child Health Science and Technology Award 2014: First Prize, 27th East China Science and Technology Press Excellent Science and Technology Book Award 2014: First Prize, Shanghai Book Award 2008: First Prize, Shanghai Excellent Book Award 2006: Silver Award, 4th Xu Guangqi Science and Technology Award, Xuhui District, Shanghai 2002: First Prize, Shanghai Excellent Invention Selection Competition

University/Lab Affiliation and Title

Fudan University

Faculty

Basic Medical Sciences

Academic Background & Achievements

2000-2002: Postdoctoral Research, University of New Mexico School of Medicine, Department of Pathology
1998-2000: Postdoctoral Research, Peking Union Medical College/Beijing Union Medical College Hospital, Department of Cardiology
1995-1998: Ph.D. in Biochemistry and Molecular Biology, Shanghai Medical College
1985-1988: Master's in Hematology, Shandong Medical University
1979-1982: Medical Degree, Wuhan University of Science and Technology School of Medicine

Work Experience

2008.5-present: Deputy Director, Birth Defect Research Center, Fudan University
2002.4-present: Deputy Director, Key Laboratory of Metabolic Molecular Medicine, Ministry of Education, Fudan University, Professor
1988.9-2000.9: Director, Thrombosis Research Center, Shandong Third People's Hospital, Associate Chief Physician
1982.8-1985.8: Resident Physician, Internal Medicine, Anyang Steel Company Hospital, Henan

Awards

2015: First Prize, China Maternal and Child Health Science and Technology Award
2014: First Prize, 27th East China Science and Technology Press Excellent Science and Technology Book Award
2014: First Prize, Shanghai Book Award
2008: First Prize, Shanghai Excellent Book Award
2006: Silver Award, 4th Xu Guangqi Science and Technology Award, Xuhui District, Shanghai
2002: First Prize, Shanghai Excellent Invention Selection Competition

Areas of Focus	Pathogenesis and prevention strategies of genetic-related diseases
Publications	STARD3NL inhibits the osteogenic differentiation by inactivating the Wnt/β-catenin pathway via binding to Annexin A2 in osteoporosis., Xu Y, Bao X, Chen X, Wu P, Chen S, Zhang B, Ma J, Xu G, Ma D, 2022 Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression., Weng ML, Chen WK, Chen XY, Lu H, Sun ZR, Yu Q, Sun PF, Xu YJ, Zhu MM, Jiang N, Zhang J, Zhang JP, Song YL, Ma D, Zhang XP, Miao CH, 2020 SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms., He J, Zhou M, Li X, Gu S, Cao Y, Xing T, Chen W, Chu C, Gu F, Zhou J, Jin Y, Ma J, Ma D, Zou Q, 2020 Novel TRRAP mutation causes autosomal dominant non-syndromic hearing loss., Xia W, Hu J, Ma J, Huang J, Wang X, Jiang N, Zhang J, Ma Z, Ma D, 2019 Delivery of Glucosylceramidase Beta Gene Using AAV9 Vector Therapy as a Treatment Strategy in Mouse Models of Gaucher Disease., Du S, Ou H, Cui R, Jiang N, Zhang M, Li X, Ma J, Zhang J, Ma D, 2019 The roles of SMYD4 in epigenetic regulation of cardiac development in zebrafish., Xiao D, Wang H, Hao L, Guo X, Ma X, Qian Y, Chen H, Ma J, Zhang J, Sheng W, Shou W, Huang G, Ma D, 2018 Epigenetic regulation of megakaryocytic and erythroid differentiation by PHF2 histone demethylase., Yang J, Ma J, Xiong Y, Wang Y, Jin K, Xia W, Chen Q, Huang J, Zhang J, Jiang N, Jiang S, Ma D, 2018 New role of LRP5, associated with non-syndromic autosomal recessive hereditary hearing loss., Xia W, Hu J, Liu F, Ma J, Sun S, Zhang J, Jin K, Huang J, Jiang N, Wang X, Li W, Ma Z, Ma D, 2017 SLC44A4 mutation causes autosomal dominant hereditary postlingual non-syndromic mid-frequency hearing loss., Ma Z, Xia W, Liu F, Ma J, Sun S, Zhang J, Jiang N, Wang X, Hu J, Ma D, 2017 Conditional knockout of TFPI-1 in VSMCs of mice accelerates atherosclerosis by enhancing AMOT/YAP pathway., Xiao JJ, Jin KY, Wang JP, Ma J, Zhang J, Jiang N, Wang HJ, Luo XP, Fei J, Wang ZG, Yang X, Ma D, 2017

Areas of Focus

Pathogenesis and prevention strategies of genetic-related diseases

Publications

STARD3NL inhibits the osteogenic differentiation by inactivating the Wnt/β-catenin pathway via binding to Annexin A2 in osteoporosis., Xu Y, Bao X, Chen X, Wu P, Chen S, Zhang B, Ma J, Xu G, Ma D, 2022
Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression., Weng ML, Chen WK, Chen XY, Lu H, Sun ZR, Yu Q, Sun PF, Xu YJ, Zhu MM, Jiang N, Zhang J, Zhang JP, Song YL, Ma D, Zhang XP, Miao CH, 2020
SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms., He J, Zhou M, Li X, Gu S, Cao Y, Xing T, Chen W, Chu C, Gu F, Zhou J, Jin Y, Ma J, Ma D, Zou Q, 2020
Novel TRRAP mutation causes autosomal dominant non-syndromic hearing loss., Xia W, Hu J, Ma J, Huang J, Wang X, Jiang N, Zhang J, Ma Z, Ma D, 2019
Delivery of Glucosylceramidase Beta Gene Using AAV9 Vector Therapy as a Treatment Strategy in Mouse Models of Gaucher Disease., Du S, Ou H, Cui R, Jiang N, Zhang M, Li X, Ma J, Zhang J, Ma D, 2019
The roles of SMYD4 in epigenetic regulation of cardiac development in zebrafish., Xiao D, Wang H, Hao L, Guo X, Ma X, Qian Y, Chen H, Ma J, Zhang J, Sheng W, Shou W, Huang G, Ma D, 2018
Epigenetic regulation of megakaryocytic and erythroid differentiation by PHF2 histone demethylase., Yang J, Ma J, Xiong Y, Wang Y, Jin K, Xia W, Chen Q, Huang J, Zhang J, Jiang N, Jiang S, Ma D, 2018
New role of LRP5, associated with non-syndromic autosomal recessive hereditary hearing loss., Xia W, Hu J, Liu F, Ma J, Sun S, Zhang J, Jin K, Huang J, Jiang N, Wang X, Li W, Ma Z, Ma D, 2017
SLC44A4 mutation causes autosomal dominant hereditary postlingual non-syndromic mid-frequency hearing loss., Ma Z, Xia W, Liu F, Ma J, Sun S, Zhang J, Jiang N, Wang X, Hu J, Ma D, 2017
Conditional knockout of TFPI-1 in VSMCs of mice accelerates atherosclerosis by enhancing AMOT/YAP pathway., Xiao JJ, Jin KY, Wang JP, Ma J, Zhang J, Jiang N, Wang HJ, Luo XP, Fei J, Wang ZG, Yang X, Ma D, 2017

Genetic Diseases Pathogenesis Prevention Strategies Research Genetics Molecular Biology Biochemistry Therapeutics Clinical Studies

Guoheng Xu - Peking University

Wei Zhen Zhang - Peking University

Kong Wei - Peking University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us